Postes actifs de Hema Keshava
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CINCOR PHARMA, INC. | Comptroller/Controller/Auditor | 01/11/2021 | - |
| ABIVAX | Corporate Officer/Principal | 01/07/2023 | - |
Historique de carrière de Hema Keshava
Statistiques
Internationale
| Etats-Unis | 2 |
| France | 2 |
Opérationnelle
| Comptroller/Controller/Auditor | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABIVAX | Health Technology |
| Entreprise privées | 1 |
|---|---|
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Hema Keshava
- Expérience
